Skip to product information
1 of 1

GeneBio Systems

FITC Anti-Mouse CD279/PD-1 Antibody[29F.1A12]

FITC Anti-Mouse CD279/PD-1 Antibody[29F.1A12]

SKU:GBS-F1131UC

Regular price €239,95 EUR
Regular price Sale price €239,95 EUR
Sale Sold out
Shipping calculated at checkout.

Size:100μg

Storage:This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Flow Cytometry Antibodies

Abbreviation:CD279;PD-1

Target Synonym:Programmed Death-1;PD-1

Research Areas:Cancer Biomarkers;Immunology;Inhibitory Molecules

Conjugation:FITC

Host:Rat

Species reactivity:Mouse

Application:FCM

Usage:Each lot of this antibody is quality control tested by flow cytometric analysis. Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. We suggest each investigator should titrate the reagent to obtain optimal results [The recommended concentration is 0.1-1 μg/106 cells in 100 μL volume].

Isotype:Rat IgG2a, κ

Clonality:Monoclonal

Clone NO.:29F.1A12

UNIProt ID:Q02242

Background:CD279, also known as programmed death-1 (PD-1), is a 50-55 kD glycoprotein belonging to the CD28 family of the Ig superfamily. PD-1 is expressed on activated splenic T and B cells and thymocytes. It is induced on activated myeloid cells as well. PD-1 is involved in lymphocyte clonal selection and peripheral tolerance through binding its ligands, B7-H1 (PD-L1) and B7-DC (PD-L2). It has been reported that PD-1 and PD-L1 interactions are critical to positive selection and play a role in shaping the T cell repertoire. PD-L1 negative costimulation is essential for prolonged survival of intratesticular islet allografts.

Concentration:0.5 mg/mL

Control catalog number:E-AB-F09833C

Immunogen:

Buffer:Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.

Purification method:

Dilution:

GeneID:18566

View full details